About Genycell Biotech
Genycell Biotech is a Healthcare company based in Granada (Spain) founded in 2001, and was acquired by Alantra in December 2019. It offers products and services in molecular biology. Genycell Biotech offers products and services including NGS Services, MLPA, digitalMLPA, MELT, and BiologÃa Molecular. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is Genycell Biotech España SL.
Company details
Genycell Biotech was founded in 2001 in Granada, Spain, and operates within the biotechnology sector. Focus is placed on molecular biology research through the supply of products and services, with specialization in next-generation sequencing (NGS) reagents. The product range encompasses NGS reagents, MLPA kits, arrays, cytogenetics tools including FISH probes, and standard molecular biology items such as qPCR assays, cloning vectors, and sequencing supplies. Operations are centered in Europe.
- Headquarters Granada, Spain
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website genycell.com
- Social LinkedIn X
- Acquired by Alantra (Dec 2019)
- Legal Name Genycell Biotech España Sl
Products & Services of Genycell Biotech
Genycell Biotech offers a comprehensive portfolio of products and services, including NGS Services, MLPA, digitalMLPA, MELT, and Biología Molecular.
Provides next-generation sequencing for research and clinical diagnosis.
Offers multiplex ligation-dependent probe amplification for DNA testing.
Digital version of MLPA for enhanced genetic diagnostics.
Services for mobile element insertion detection in genomics.
General molecular biology solutions for laboratories.
Investors in Genycell Biotech
Genycell Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alantra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global mid-market investment banking services are provided across sectors. | 2001 | alantra.com | London, United Kingdom |
Investor details for Genycell Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genycell Biotech
2 dated milestones of Genycell Biotech across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Genycell Biotech is founded.
- Exit Acquired by Alantra.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genycell Biotech
Genycell Biotech was founded in 2001.
Genycell Biotech is headquartered in Granada, Spain. It is registered at Granada, Andalucia, Spain.
Genycell Biotech was founded in 2001 in Granada, Spain, and operates within the biotechnology sector. Focus is placed on molecular biology research through the supply of products and services, with specialization in next-generation sequencing (NGS) reagents. The product range encompasses NGS reagents, MLPA kits, arrays, cytogenetics tools including FISH probes, and standard molecular biology items such as qPCR assays, cloning vectors, and sequencing supplies. Operations are centered in Europe.
Genycell Biotech offers NGS Services, MLPA, digitalMLPA, MELT, and BiologÃa Molecular.
Genycell Biotech has 1 investor. Key investors include Alantra.
Genycell Biotech operates through Genycell Biotech España Sl.
Yes. Genycell Biotech was acquired by Alantra in December 2019.